The Women's Tennis Association (WTA) has announced that players will be required to undergo a one-time test for the SRY gene, which is used to determine biological sex. This decision is part of the association's eligibility requirements for female players.
✓ AI-Debiased Article
4
Wire-neutral
provisional
✓ No loaded language, vague sourcing, or framing detected.
WTA mandates one-time SRY gene test for women's tennis players
The Women's Tennis Association has implemented a new eligibility requirement for female players, mandating a one-time test for the SRY gene, which plays a role in determining biological sex. This measure aims to establish clear eligibility criteria within the sport.
Annotating as
No note attached
on this article.
Original vs. Neutral
Original Headline
Women’s tennis players must take one-time gene test for eligibility
Neutral Headline
WTA mandates one-time SRY gene test for women's tennis players